Abingworth as of Sept. 30, 2021
Portfolio Holdings for Abingworth
Abingworth holds 20 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vaxcyte Common (PCVX) | 24.0 | $106M | 4.2M | 25.37 | |
| eFFECTOR Common | 15.2 | $67M | 4.8M | 13.90 | |
| Jasper Common | 13.2 | $58M | 5.6M | 10.31 | |
| Vera Common (VERA) | 11.7 | $51M | 3.0M | 17.35 | |
| Phathom Common (PHAT) | 8.7 | $39M | 1.2M | 32.01 | |
| Sierra Oncology Common | 4.3 | $19M | 877k | 21.71 | |
| Reneo Common (RPHM) | 3.5 | $15M | 2.1M | 7.38 | |
| Sientra Common | 3.1 | $14M | 2.3M | 5.73 | |
| Verona Sponds Adr (VRNA) | 3.0 | $13M | 2.5M | 5.45 | |
| Adicet Common (ACET) | 2.9 | $13M | 1.6M | 7.83 | |
| Spruce Bio Common | 2.4 | $11M | 1.8M | 5.98 | |
| Soleno Common | 2.2 | $9.5M | 10M | 0.92 | |
| Nucana Adr (NCNA) | 1.9 | $8.6M | 3.3M | 2.57 | |
| Exicure Common | 1.9 | $8.2M | 7.0M | 1.18 | |
| Paratek Common | 1.1 | $5.1M | 1.0M | 4.86 | |
| Aeglea Common | 0.4 | $1.9M | 241k | 7.95 | |
| Molecular Templates Common | 0.3 | $1.3M | 200k | 6.70 | |
| Cymabay Common | 0.1 | $478k | 131k | 3.65 | |
| Obseva Common | 0.1 | $274k | 88k | 3.11 | |
| Ocugen Common | 0.0 | $51k | 7.1k | 7.17 |
